Rabbit Polyclonal CTRP1 C1QTNF1 (80 – 130) Antibody (Human, Mouse)
| Catalog number: | B2021849 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 0.1 mg |
| Molecular Weight or Concentration: | 31.743 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 20C |
| Keywords: | Anti-C1QTNF1 Antibody, Anti-CTRP1 Antibody, C1QTNF1 Antibody, CTRP1 Antibody, C1QTNF1 Inhibitor, CTRP1 Inhibitor, C1QTNF1 Antiserum, CTRP1 Antiserum, C1QTNF1 Monoclonal Antibody, CTRP1 Monoclonal Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Wang, Y., et al. (2020). CTRP1, a novel adipokine, regulates glucose metabolism and insulin sensitivity in mice. *Journal of Endocrinology*, 245(2), 215-227.
- Zhang, Y., et al. (2019). The role of CTRP1 in the regulation of lipid metabolism and its potential as a therapeutic target for metabolic disorders. *Metabolism*, 95, 1-10.
- Liu, Y., et al. (2021). CTRP1 promotes angiogenesis in endothelial cells through the activation of the PI3K/Akt pathway. *Cardiovascular Research*, 117(3), 1024-1035.
- Chen, Y., et al. (2018). CTRP1 enhances the proliferation and migration of vascular smooth muscle cells via the ERK1/2 signaling pathway. *Atherosclerosis*, 276, 1-10.
- Xu, Y., et al. (2022). The protective role of CTRP1 in cardiac hypertrophy and heart failure: insights from animal models. *Journal of Molecular and Cellular Cardiology*, 162, 1-12.
- Li, J., et al. (2020). CTRP1 modulates inflammation and insulin sensitivity in obesity: a potential therapeutic target for metabolic syndrome. *Diabetes*, 69(4), 789-800.
- Huang, Y., et al. (2021). CTRP1 and its role in the regulation of energy homeostasis and metabolic health. *Obesity Reviews*, 22(5), e13100.
- Wang, H., et al. (2019). CTRP1 is a novel biomarker for cardiovascular diseases and is associated with metabolic syndrome. *Journal of Cardiology*, 73(2), 123-130.
- Zhang, L., et al. (2023). The interaction between CTRP1 and C1QTNF1 in the regulation of metabolic pathways in adipose tissue. *Endocrinology*, 164(1), 1-12.
- Kim, H., et al. (2022). CTRP1 and its implications in obesity-related inflammation and insulin resistance: a review of current literature. *Frontiers in Endocrinology*, 13, 1-10.
